J&J to invest as much as $13M in Enlight Biosciences

01/22/2009 | Xconomy

Johnson & Johnson became the latest major firm to partner with Enlight Biosciences, joining the ranks of Eli Lilly and Co., Merck & Co. and Pfizer. Enlight strives to find technology in areas such as molecular imaging that could help in drug discovery and development. A J&J official said the project will help the drugmaker "identify technology needs and influence future industry standards."

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC